WS was clinically suspected but not confirmed by WES which revealed a pathogenic (class 5) truncating variant in the CEBPA gene, associated with familial AML, in the patient’s urine (own DNA) and blood (sister’s DNA). The gene discussed is CEBPA; the disease is acute myeloid leukemia.